Echo Therapeutics Inc (NASDAQ:ECTE)

2.60
Delayed Data
As of Mar 26
 +0.005 / +0.19%
Today’s Change
0.39
Today|||52-Week Range
3.47
+92.22%
Year-to-Date
No recent news for Echo Therapeutics Inc.

Today’s Trading

Previous close2.59
Today’s open2.51
Day’s range-- - --
Volume55,512
Average volume (3 months)82,233
Market cap$32.7M
Dividend yield--
Data as of 03/26/2015

Growth & Valuation

Earnings growth (last year)+24.84%
Earnings growth (this year)+59.66%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+439.17%
P/E ratioNM
Price/Sales951.08
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
CYCCCyclacel Pharmaceuti...+0.01+0.81%
SKBISkystar Bio-Pharmace...-0.02-0.50%
BIODBiodel Inc+0.01+0.83%
ACURAcura Pharmaceutical...+0.04+5.34%
Data as of 03/26/2015

Financials

Last reporting dateMarch 26, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$27.6K
Annual profit (last year)-$19.1M
Net profit margin-69,084.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Scott Wayne Hollander
Vice President-Operations &
Product Development
Thomas H. Bishop
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account